Abstract
For patients infected with tuberculosis, detection of rpoB gene mutations is critical for diagnosing drug-resistant strains of the causative pathogen, Mycobacterium tuberculosis (MTB). Traditional approaches to drug resistance include culture, which is very slow. Recently described real-time polymerase chain reaction approaches have addressed turnaround time but at relatively high cost. Here, we describe a novel amplification method, termed blocked-primer helicase-dependent amplification, for amplifying rpoB gene sequences in MTB. Resultant amplicon is hybridized to a probe set arrayed on a modified silicon-based chip to determine if there is any mutation in that region. Using this method, we could detect the majority of clinically relevant mutations in rpoB gene.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization: Anti-Tuberculosis Drug Resistance in the World: Fourth Global Report (2008) The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. World Health Organization, Geneva, Switzerland, Publication no. WHO/HTM/TB/2008.394
Caws M, Duy PM, Tho DQ, Lan NT, Hoa DV, Farrar J (2006) Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 44:2333–2337
Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK et al (2007) Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 59:866–873
Heep M, Brandstätter B, Rieger U, Lehn N, Richter E, Rüsch-Gerdes S et al (2001) Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 39:107–110
Herrera L, Jiménez S, Valverde A, GarcÃa-Aranda MA, Sáez-Nieto JA (2003) Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 21:403–408
Mani C, Selvakumar N, Kumar V, Narayanan S, Narayanan PR (2003) Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 7:652–659
Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P et al (1997) Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 41:2093–2098
Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y et al (1998) Relationship between antimycobacterial activities of rifampin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother 42:621–628
Millen SJ, Uys PW, Hargrove J, van Helden PD, Williams BG (2008) The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One 3:e1933
Mitnick CD, Appeton SC, Shin SS (2008) Epidemiology and treatment of multidrug resistant tuberculosis. Semin Respir Crit Care Med 29:499–524
Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ et al (2008) Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 359:563–574
Perkins MD, Cunningham J (2007) Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196:S15–S27
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F et al (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005–1015
Nordhoek GT, van Embden JD, Kolk AH (1996) Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 34:2522–2525
Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6:423–432
Suffys P, Palomino JC, Cardaso Leao S, Espitia C, Cataldi A, Alito A et al (2000) Evaluation of the polymerase chain reaction for the detection of Mycobaterium tuberculosis. Int J Tuberc Lung Dis 4:179–183
Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ et al (1993) Detection of rifampin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647–650
Ao W, Aldous S, Woodruff E, Hicke B, Larry R, Kreiswirth B et al (2012) Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 50:2433–2440
Dobosy JR, Rose SD, Beltz KR, Rupp SM, Powers KM, Behlke MA et al (2011) RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers. BMC Biotechnol 11:80
Jenison R, La H, Haeberli A, Ostroff R, Polisky B (2001) Silicon-based biosensors for rapid detection of protein or nucleic acid targets. Clin Chem 47:1894–1900
Miller LP, Crawford JT, Shinnick TM (1994) The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 38:805–811
Acknowledgments
We thank Adrianne Clifford and all other members of the Research Group at Great Basin Corporation for technical assistance and Steve Aldous for financial support for this project.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Ao, W., Jenison, R. (2013). Detection of rpoB Gene Mutations Using Helicase-Dependent Amplification. In: Kolpashchikov, D., Gerasimova, Y. (eds) Nucleic Acid Detection. Methods in Molecular Biology, vol 1039. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-535-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-535-4_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-534-7
Online ISBN: 978-1-62703-535-4
eBook Packages: Springer Protocols